The effects of A 5-HT(1A) receptor agonist and antagonist on the 5-hydroxytryptamine release in the central nucleus of the amygdala: A microdialysis study with flesinoxan and WAY 100635

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 355, Issue 3, 1997, Pages 347-353

  Bosker, Fokko ^a   Vrinten, Dorien ^a   Klompmakers, André ^a   Westenberg, Herman ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

5 HT(1A) receptors; 5 Hydroxytryptamine; 8 OH DPAT; Flesinoxan; Microdialysis; Rat; WAY 100635

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; FLESINOXAN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A RECEPTOR; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDINYL)1H INDOLE; 5-METHOXY 3-(1,2,3,6-TETRAHYDRO-4-PYRIDINYL)1H INDOLE; INDOLE DERIVATIVE; PIPERAZINE DERIVATIVE; POTASSIUM CHLORIDE; PYRIDINE DERIVATIVE; SEROTONIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; TETRODOTOXIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; MALE; MICRODIALYSIS; NONHUMAN; RAT; REGIONAL PERFUSION; SEROTONIN RELEASE; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; DRUG EFFECT; IN VITRO STUDY; METABOLISM; WISTAR RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; AMYGDALA; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOLES; MALE; MICRODIALYSIS; PIPERAZINES; POTASSIUM CHLORIDE; PYRIDINES; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TETRODOTOXIN;

EID: 0030610883     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00004953     Document Type: Article

References (45)

1. Adell A, Carceller A, Artigas F (1993) In vivo brain dialysis study of the somatodendritic release of serotonin in the raphe nuclei of the rat: Effects of 8-hydroxy-2-(di-n-propylamino)tetralin. J Neurochem 60: 1673-1681
2. Aggleton JP (1992) The functional effects of amygdala lesion in humans: A comparison with findings from monkeys. In: Aggleton JP (ed) The amygdala. Neurobiological aspects of emotion, memory and mental dysfunction. John Wiley-Liss and Sons, pp 485-503
3. 1A receptor agonists flesinoxan and 8-OH-DPAT in the rat. Eur J Pharmacol 200: 259-266
4. Amaral DG, Price JL, Pitkänen A, Carmichael ST (1992) Anatomical organization of the primate amygdaloid complex. In: Aggleton JP (ed) The amygdala. Neurobiological aspects of emotion, memory and mental dysfunction. John Wiley-Liss and Sons, pp 1-66
5. 1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY 100135, but not WAY 100635, has partial agonist properties. Eur J Pharmacol 304:15-21
6. Azmitia EC, Gannon PJ (1986) The primate serotonergic system. A review of human and animal studies and a report on macaca fascicularis. Adv Neurol 43: 407-468
7. Azmitia EC, Segal M (1978) An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 179:641-668
8. 1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1: 470-480
9. Bonvento G, Scatton B, Claustre Y, Rouquier L (1992) Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain. Neurosci Lett 137: 101-104
10. Bosch AI, van Hove N, Long SK, de Rond EJ (1994) Systemic flesinoxan depresses hippocampal 5-HT release in the freely-moving guinea-pig. (abstract) Br J Pharmacol 112: 94P
11. Bosker EJ, Donker MG, Klompmakers AA, Kurata K, Westenberg HGM (1994a) 5-Hydroxytryptamine release in dorsal hippocampus of freely moving rats: Modulation by pindolol. Prog NeuroPsychopharmacol Biol Psychiatry 18: 765-778
12. Bosker FJ, Klompmakers AA, Westenberg HGM (1994b) Extracellular 5-hydroxytryptamine in median raphe nucleus of the conscious rat is decreased by nanomolar concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin and is sensitive to tetrodotoxin. J Neurochem 63: 2165-2171
13. 1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats. Psychopharmacology 117: 358-363
14. Bosker FJ, Klompmakers AA, Westenberg HGM (1995b) Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat. Neuropharmacology 34: 501-508
15. 1A receptors. J Neurochem 66: 2546-2555
16. Bradford LD, Stevens G (1994) Double-blind placebo controlled fixed dose studies of flesinoxan in generalized anxiety disorders (abstract) ACNP, Puerto Rico p 167
17. 1D-like autoreceptors in the guinea-pig brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 353:281-289
18. Davis M (1992a) The amygdala and conditioned fear. In: Aggleton JP (ed) The amygdala. Neurobiological aspects of emotion, memory and mental dysfunction. John Wiley-Liss and Sons, pp 255-305
19. Davis M (1992b) The role of the amygdala in fear-potentiated startle. Implications for animal models of anxiety. Trends Pharmacol Sci 13: 35-41
20. 1A receptor antagonist. Behav Brain Res 73:337-353
21. Graeff FG, Siveira MCL, Nogueira RL, Audi EA, Oliveira RMW (1993) Role of the amygdala and periaqueductal gray in anxiety and panic. Behav Brain Res 58:123-131
22. 1A receptor agonist, in treatment-resistant depression. Int Clin Psychopharmacol 8: 167-172
23. Hitchcock JM, Davis M (1991) Efferent pathways of the amygdala involved in conditioned fear as measured with the fear-potentiated startle paradigm. Behav Neurosci 105: 826-842
24. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo - a microdialysis study. J Neurochem 60: 776-779
25. 1A autoreceptors of the dorsal and median raphe nuclei. J Pharmacol Exp Ther 269: 1268-1279
26. Matsuzaki S, Takada M, Li YQ, Tokuno H, Mizuno N (1993) Serotonergic projections from the dorsal raphe nucleus to the nucleus submedius in the rat and cat. Neuroscience 55: 403-416
27. Mehler WR (1980) Subcortical afferent connections of the amygdala in the monkey. J Comp Neurol 190: 733-762
28. 1A antagonist WAY 100635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing. Br J Pharmacol 117:750-756
29. Ohuoha DC, Hyde TM, Kleinman JE (1993) The role of serotonin in schizophrenia. An overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system. Psychopharmacology 112: S5-S15
30. 3H-hydroxytryptamine. Neuroscience 6: 115-138
31. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, Sydney
32. 1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT. Psychopharmacology 125:89-91
33. Sadikot AF, Parent A (1990) The monoaminergic innervation of the amygdala in the squirrel monkey. An immunohistochemical study. Neuroscience 36: 431-447
34. Santiago M, Westerink BHC (1990) Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes. Naunyn-Schmiedeberg's Arch Pharmacol 342: 407-414
35. Schipper J, Tulp MTM, Sybesma H (1990) Neurochemical profile of eltoprazine. Drug Metab Drug Inter 8: 85-114
36. 1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol 96: 283-290
37. Sharp T, Bramwell SR, Hjorth S, Grahame-Smith DG (1989b) Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Br J Pharmacol 98: 989-997
38. Sharp T, Bramwell SR, Grahame-Smith DG (1990) Release of endogenous 5-hydroxytryptamine in rat ventral hippocampus evoked by electrical stimulation of the dorsal raphe nucleus as detected by microdialysis: Sensitivity to tetrodotoxin, calcium and calcium antagonists. Neuroscicnce 39: 629-637
39. 1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur J Neurosci 12: 1144-1154
40. 1B agonists. Synapse 1: 3-9
41. Treit D, Pesold C, Rotzinger S (1993) Dissociating the anti-fear effects of septal and amygdaloid lesions using two pharmacologically validated models of rat anxiety. Behav Neurosci 107: 770-785
42. Westenberg HGM, den Boer, JA (1994) The neuropharmacology of anxiety. In: den Boer JA, Sitsen JAM (eds) Handbook of Depression and Anxiety. Marcel Dekker, New York, pp 405-447
43. Westerink BHC, Damsma G, Rollema H, De Vries JB, Horn AS (1987) Scope and limitations of in vivo brain dialysis. A comparison of its application to various neurotransmitter systems. Life Sci 41: 1763-1776
44. 1A receptors. Eur J Pharmacol 149: 213-223
45. Ybema CE, Slangen JL, Olivier B, Mos J (1990) Discriminative stimulus properties of flesinoxan. Pharmacol Biochem Behav 35: 781-784